In a letter to the DEA, ASHP and its partners pointed out that pharmacists in five states — Colorado, Iowa, Nevada, North Dakota and Oregon — are authorized to prescribe controlled substances but are not listed on the DEA’s “Mid-Level Practitioners Authorization by State ” table.
The omission prevents pharmacists from obtaining DEA registration, limiting their ability to prescribe medications, including those for opioid use disorder, according to a March 4 ASHP news release.
The organization is urging the DEA to update its policies to remove the barriers that prevent pharmacists from fully utilizing prescriptive authority.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
